Q: I have noticed SVI has tumbled from $2.60 to the $2.25 range lately.
I hold it as a small component in my TFSA (8%),
and am contemplating adding to my portfolio.
Would you recommend buying more at this level?
For a 1-3 year time horizon.
Thanks as always for your advice.
Steve
Q: What is 5i's opinion on Chesswood Group, earlier last week market call had it as a top pick; a great dividend. Does it have capital appreciation potential. Great Service....Wayne
Q: What can you tell me about this small cap biotech it's obviously high risk but do you think it has any potential and do they have any products on the markets yet thank you
Q: Hi, Wondering your thoughts on PDH (Premier Diversified Holdings) on the CSE. I have taken a position as a bet on the jockey (CEO-Sanjeev Parsad) and his ability to invest and grow the business over the long term. Also, I like the idea of some exposure to their start-up / venture style investments (E.g. Sequant Re, MyCare Medtech etc). However, in saying that I understand the risks given the balance sheet and illiquidity so just looking for a second opinion on a stock like this in ones portfolio.
Q: What are your thoughts on Input Capital? Was thinking of initiating a small position. What is the main risk to this business and what would be the catalyst to move the stock forward?
Q: Hi Guys, if you were to put money to work in one or two Canadian microcaps today...what would you choose. This is approx. 2% of a diversified portfolio...thx
Q: All seems well here? I've let it run to an overweight position, especially for the size of company, whats the biggest company risk you see going forward?
Q: With news out this morning that BUS will have its first profitable quarter and production is ramping up would it be a good time at add to an existing position? It sounds like some of the execution risk is starting to be eliminated.
Q: I am interested in Village Farms to diversify my holdings in the marijuana sector and it seems like a safer play, currently I just hold ICC for a speculative play on South America.
What are the key metrics on VFF, earnings, book value, P/E etc… and would you consider this a good entry point now that it has come off its recent high after the Emerald Health joint venture announcement?